Junping Ao
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
-
- Nanoparticle-Based Drug Delivery 4
-
- RNA Interference and Gene Delivery 3
- Mechanisms of cancer metastasis 2
- Circular RNAs in diseases 2
- Connective Tissue Growth Factor Research 2
- Co-authors
- Ji Wu (2 shared papers)Xiaofei Liang (6 shared papers)Jianren Gu (3 shared papers)Weiwei Cheng (1 shared paper)Xinyue Li (1 shared paper)Huijuan Zhang (1 shared paper)Bizhi Shi (2 shared papers)Zonghai Li (2 shared papers)
- Journals
- Oncotarget (3 papers)Clinical Epigenetics (1 paper)Bioconjugate Chemistry (1 paper)Journal of Molecular Cell Biology (1 paper)Psychopharmacology (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Junping Ao
24 papers receiving 732 citations
Peers
Comparison fields: 5 of 71
- Biomaterials 117
- Pharmaceutical Science 49
- Cancer Research 65
- Molecular Biology 299
- Hepatology 36
Countries citing papers authored by Junping Ao
This map shows the geographic impact of Junping Ao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junping Ao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junping Ao more than expected).
Fields of papers citing papers by Junping Ao
This network shows the impact of papers produced by Junping Ao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junping Ao. The network helps show where Junping Ao may publish in the future.
Co-authors
The 25 scholars most cited alongside Junping Ao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 79 | |
| 2 | 2017 | 78 | |
| 3 | 2015 | 75 | |
| 4 | 2017 | 54 | |
| 5 | 2015 | 51 | |
| 6 | 2018 | 44 | |
| 7 | 2012 | 40 | |
| 8 | 2014 | 40 | |
| 9 | 2016 | 40 | |
| 10 | 2015 | 38 | |
| 11 | 2017 | 35 | |
| 12 | 2015 | 29 | |
| 13 | 2021 | 20 | |
| 14 | Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling. | 2014 | 19 |
| 15 | 2015 | 17 | |
| 16 | 2018 | 15 | |
| 17 | 2020 | 15 | |
| 18 | 2021 | 14 | |
| 19 | 2016 | 11 | |
| 20 | Dysregulated cell mechanical properties of endometrial stromal cells from endometriosis patients. | 2014 | 10 |
About Junping Ao
Junping Ao is a scholar working on Biomaterials, Molecular Biology, Gastroenterology, Cancer Research and Reproductive Medicine, having authored 25 papers that have together received 740 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (3 papers), Gastrointestinal motility and disorders (3 papers), Mechanisms of cancer metastasis (2 papers), Circular RNAs in diseases (2 papers), Connective Tissue Growth Factor Research (2 papers), Pain Mechanisms and Treatments (2 papers) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Biomaterials (117 citations), Pharmaceutical Science (49 citations), Cancer Research (65 citations), Molecular Biology (299 citations) and Hepatology (36 citations). Junping Ao has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Ji Wu, Xiaofei Liang, Jianren Gu, Weiwei Cheng, Xinyue Li, Huijuan Zhang, Bizhi Shi, Zonghai Li, Mingliang Fan and Kai Wang. Their work appears in journals such as Oncotarget, Clinical Epigenetics, Bioconjugate Chemistry, Journal of Molecular Cell Biology and Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.